An increase of the thioredoxin reductase/thioredoxin (TrxR/Trx) system has been reported in many tumors compared to normal tissues and the ability of certain cancer cells to maintain a highly reduced intracellular environment is correlated with tumor aggressiveness and drug resistance. The gene discussed is TXN; the disease is cancer.